Hypertrophy, Left Ventricular

• 

  Subject Areas on Research

  • A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study. 
  • A comparison of methods for the detection of myocardial ischemia during noncardiac surgery: automated ST-segment analysis systems, electrocardiography, and transesophageal echocardiography. 
  • A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement. 
  • Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. 
  • Aetiology and incidence of sudden cardiac arrest and death in young competitive athletes in the USA: a 4-year prospective study. 
  • African American-Caucasian American differences in aortic valve replacement in patients with severe aortic stenosis. 
  • Albuminuria and kidney function as prognostic marker of left ventricular mass among South Asians with hypertension. 
  • An increase in the myocardial PCr/ATP ratio in GLUT4 null mice. 
  • An infant with subvalvar and valvar aortic stenosis, subvalvar and valvar pulmonary stenosis, severe biventricular hypertrophy and pulmonary hemorrhage. 
  • Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry. 
  • Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. 
  • Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction. 
  • Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. 
  • Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome. 
  • Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial. 
  • Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. 
  • Association between exercise capacity and left ventricular geometry in overweight patients with mild systemic hypertension. 
  • Association between morning blood pressure surge and cardiovascular remodeling in treated elderly hypertensive subjects. 
  • Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study. 
  • Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population. 
  • Association of electrocardiographic left ventricular hypertrophy with incident cardiovascular disease in Japanese older hypertensive patients. 
  • Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening. 
  • Association of parental heart failure with risk of heart failure in offspring. 
  • Associations of Blood Pressure Dipping Patterns With Left Ventricular Mass and Left Ventricular Hypertrophy in Blacks: The Jackson Heart Study. 
  • Biatrial appendage hypertrophy but not ventricular hypertrophy: a unique feature of canine pacing-induced heart failure. 
  • Body composition and source of weight loss after bariatric surgery. 
  • CT-Defined Prosthesis-Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement. 
  • Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility. 
  • Calcium signaling regulates ventricular hypertrophy during development independent of contraction or blood flow. 
  • Cardiac morphology and function in senescent rats: gender-related differences. 
  • Cardiac sarcoidosis: two cases with autopsy findings. 
  • Cardiovascular abnormalities in transgenic mice with reduced brown fat: an animal model of human obesity. 
  • Cardiovascular function in normotensive offspring of persons with essential hypertension and black race. 
  • Changes in hemodynamics and left ventricular structure after menopause. 
  • Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. 
  • Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study. 
  • Circadian hemodynamics in men and women with high blood pressure: dipper vs. nondipper and racial differences. 
  • Citius, altius, fortius (the Olympic motto: swifter, higher, stronger). 
  • Clinical methods for the detection and management of left ventricular hypertrophy. 
  • Comparison of the association of masked hypertension defined by the 2017 ACC/AHA BP guideline versus the JNC7 guideline with left ventricular hypertrophy. 
  • Complete heart block complicating retrograde left ventricular catheterization: case report and review. 
  • Correlates of left ventricular mass in chronic hemodialysis recipients. 
  • Correlation of Central Blood Pressure to Hypertensive Target Organ Damages During Antihypertensive Treatment: The J-TOP Study. 
  • Cost-effectiveness of electrocardiography vs. electrocardiography plus limited echocardiography to diagnose LVH in young, newly identified, hypertensives. 
  • Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study. 
  • Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgery. 
  • Detection of subclinical fabry disease in patients presenting with hypertrophic cardiomyopathy. 
  • Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical Cohort. 
  • Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. 
  • Disproportionately high risk of left ventricular hypertrophy in Indo-Asian women: a call for more studies. 
  • Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. 
  • Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. 
  • Echocardiographic quantification of left ventricular mass: prognostic implications. 
  • Effects of exercise, diet and weight loss on high blood pressure. 
  • Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women. 
  • Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy. 
  • Electrocardiographic left ventricular strain pattern: everything old is new again. 
  • Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. 
  • Ethnic differences in left ventricular structure: relations to hemodynamics and diurnal blood pressure variation. 
  • Evaluating strict and conventional left bundle branch block criteria using electrocardiographic simulations. 
  • Evaluation of right and left ventricular diastolic filling. 
  • Extracellular superoxide dismutase regulates cardiac function and fibrosis. 
  • FGF23 and Left Ventricular Hypertrophy in Children with CKD. 
  • FGF23 induces left ventricular hypertrophy. 
  • FGF23/FGFR4-mediated left ventricular hypertrophy is reversible. 
  • Familial aggregation of left ventricular geometry and association with parental heart failure: the Framingham Heart Study. 
  • Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. 
  • Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. 
  • Fibroblast growth factor receptor 4: the missing link between chronic kidney disease and FGF23-induced left ventricular hypertrophy? 
  • Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study. 
  • Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry. 
  • Gender differences in molecular remodeling in pressure overload hypertrophy. 
  • Genetic Dissection of Cardiac Remodeling in an Isoproterenol-Induced Heart Failure Mouse Model. 
  • Genetic background influences cardiac phenotype in murine chronic kidney disease. 
  • Glycogen storage diseases presenting as hypertrophic cardiomyopathy. 
  • Heart rate is associated with progression of atrial fibrillation, independent of rhythm. 
  • Hormone replacement improves hemodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women. 
  • How does intermittent pacing modify the response to rapid ventricular pacing in experimental heart failure? 
  • Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. 
  • Impact of on-line endocardial border detection on determination of left ventricular volume and ejection fraction by transthoracic 3-dimensional echocardiography. 
  • Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial Subanalysis. 
  • Improved left ventricular mass quantification with partial voxel interpolation: in vivo and necropsy validation of a novel cardiac MRI segmentation algorithm. 
  • In hypertension, the kidney rules. 
  • Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis. 
  • Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency. 
  • Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. 
  • Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. 
  • Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. 
  • Intrinsic myocyte dysfunction and tyrosine kinase pathway activation underlie the impaired wall thickening of adjacent regions during postinfarct left ventricular remodeling. 
  • Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. 
  • Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries. 
  • Left ventricular hypertrophy impairs detection of myocardial infarction in patients with nonischemic cardiomyopathy. 
  • Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure. 
  • Left ventricular hypertrophy in athletes. 
  • Left ventricular hypertrophy in athletes: morphologic features and clinical correlates. 
  • Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. 
  • Lin28a Regulates Pathological Cardiac Hypertrophic Growth Through Pck2-Mediated Enhancement of Anabolic Synthesis. 
  • Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. 
  • Loss of Endothelial Hypoxia Inducible Factor-Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis. 
  • Mammoth ventricular hypertrophy. 
  • Microvascular narrowing and BP monitoring: A single centre observational study. 
  • Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure. 
  • Multiple polyamine regulatory pathways control compensatory cardiovascular hypertrophy in coarctation hypertension. 
  • Nighttime blood pressure, nighttime glucose values, and target-organ damages in treated type 2 diabetes patients. 
  • Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. 
  • Paediatric cardiomyopathy and anaesthesia. 
  • Palpitations in a 64-year-old man. 
  • Physiological genomics of cardiac disease: quantitative relationships between gene expression and left ventricular hypertrophy. 
  • Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. 
  • Pressure overload induces greater hypertrophy and mortality in female mice with p38alpha MAPK inhibition. 
  • Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. 
  • Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. 
  • Racial differences in the association between heart rate variability and left ventricular mass. 
  • Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort. 
  • Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure. 
  • Real-time three-dimensional echocardiography for measurement of left ventricular volumes. 
  • Reduction of left ventricular hypertrophy after exercise and weight loss in overweight patients with mild hypertension. 
  • Reexamining electrocardiogram criteria for left ventricular hypertrophy-new concepts from an old tool. 
  • Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries. 
  • Relationship of clinic, ambulatory, and laboratory stress blood pressure to left ventricular mass in overweight men and women with high blood pressure. 
  • Retinal arteriolar narrowing and left ventricular hypertrophy in African Americans. the Atherosclerosis Risk in Communities (ARIC) study. 
  • Risk assessment for incident heart failure in individuals with atrial fibrillation. 
  • SRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heart. 
  • Self-reported Age of Hypertension Onset and Hypertension-Mediated Organ Damage in Middle-Aged Individuals. 
  • Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. 
  • Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. 
  • Short- and long-term outcomes of patients with electrocardiographic left ventricular hypertrophy after fibrinolysis for acute myocardial infarction. 
  • Should we cross the valve: the risk of retrograde catheterization of the left ventricle in patients with aortic stenosis. 
  • Specificity of electrocardiographic myocardial infarction screening criteria in patients with nonischemic cardiomyopathies. 
  • Staging classification of aortic stenosis based on the extent of cardiac damage. 
  • Structural remodelling in heart failure: gelatinase induction. 
  • Sudden Cardiac Death Among Hemodialysis Patients. 
  • T-wave alternans and ST depression assessment identifies low risk individuals with ischemic cardiomyopathy in the absence of left ventricular hypertrophy. 
  • Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. 
  • Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. 
  • The 1st symposium on ECG changes in left or right ventricular hypertension or hypertrophy in conditions of pressure overload. 
  • The 4th Report of the Working Group on ECG diagnosis of Left Ventricular Hypertrophy. 
  • The electrocardiogram in left ventricular hypertrophy: past and future. 
  • The influence of left ventricular hypertrophy on survival in patients with coronary artery disease: do race and gender matter? 
  • The interplay between CKD, sudden cardiac death, and ventricular arrhythmias. 
  • The role of ECG in the diagnosis of left ventricular hypertrophy. 
  • Three-dimensional echocardiographic measurement of left ventricular mass: comparison with magnetic resonance imaging and two-dimensional echocardiographic determinations in man. 
  • Time-varying covariates in models of human mortality and aging: multidimensional generalizations of the Gompertz. 
  • Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD. 
  • Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. 
  • Ventricular conduction and long-term heart failure outcomes and mortality in African Americans: insights from the Jackson Heart Study. 
  • [Histomorphometric study of cardiomyocytes of the left ventricle of pregnant albino rats]. 
• 

  Keywords of People

  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology